Pilot Study of 18F Fluoropaclitaxel (FPAC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 4- [F-18] fluoropaclitaxel
Sponsor: Virginia Commonwealth University